Serum heart-type fatty acid-binding protein level can be used to detect acute kidney injury on admission and predict an adverse outcome in patients with acute heart failure

Circulation Journal

Volumn 79, Issue 1, 2014, Pages 119-128

  Shirakabe, Akihiro ^a   Hata, Noritake ^a   Kobayashi, Nobuaki ^a   Okazaki, Hirotake ^a   Shinada, Takuro ^a   Tomita, Kazunori ^a   Yamamoto, Masanori ^a   Tsurumi, Masafumi ^a   Matsushita, Masato ^a   Yamamoto, Yoshiya ^a   Yokoyama, Shinya ^a   Asai, Kuniya ^b   Shimizu, Wataru ^b  

^a NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Acute decompensated heart failure; Liver fatty acid binding protein; Mortality; Neutrophil gelatinase associated lipocalin; Renal function

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; DIURETIC AGENT; FATTY ACID BINDING PROTEIN; N ACETYL BETA GLUCOSAMINIDASE; TROPONIN T; VASODILATOR AGENT; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; FABP1 PROTEIN, HUMAN; FABP3 PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ACUTE HEART FAILURE; ACUTE KIDNEY FAILURE; ADULT; ADVERSE OUTCOME; AGED; AREA UNDER THE CURVE; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INTENSIVE CARE UNIT; ISCHEMIC HEART DISEASE; LATEX AGGLUTINATION TEST; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION; VALVULAR HEART DISEASE; VERY ELDERLY; ACUTE DISEASE; ACUTE KIDNEY INJURY; ANIMAL; BLOOD; COMPLICATION; DOG; FOLLOW UP; HEART FAILURE; KAPLAN MEIER METHOD; KIDNEY FUNCTION TEST; LENGTH OF STAY; PROPORTIONAL HAZARDS MODEL; URINE;

ACUTE DISEASE; ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; AGED; ANIMALS; AREA UNDER CURVE; BIOMARKERS; CAUSE OF DEATH; DOGS; FATTY ACID-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FUNCTION TESTS; LENGTH OF STAY; LIPOCALINS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS; ROC CURVE;

EID: 84925392046     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-0653     Document Type: Article

References (25)

1. Bellomo R, Kellum JA, Ronco C. Defining and classifying acute renal failure: From advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med 2007; 33: 409-413.
2. Bellomo R, Ronco C, kellum JA, Mehta RL, Palevsky P. Acute renal failure: Definition, outcome measures, animal models, fluid therapy and information technology needs-the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212.
3. Hsieh MJ, Chen YC, Chen CC, Wang CL, Wu LS, Wang CC. Renal dysfunction on admission, worsening renal function, and severity of acute kidney injury predict 2-year mortality in patients with acute myocardial infarction. Circ J 2013; 77: 217-223.
4. Hata N, Yokoyama S, Shinada T, Kobayashi N, Shirakabe A, Tomita K, et al. Acute kidney injury and outcomes in acute decompensated heart failure: Evaluation of the RIFLE criteria in an acutely ill heart failure population. Eur J Heart Fail 2010; 12: 32-37.
5. Shirakabe A, Hata N, Kobayashi N, Shinada T, Tomita K, Tsurumi M, et al. Long-term prognostic impact after acute kidney injury in patients with acute heart failure: Evaluation of the RIFLE criteria. Int Heart J 2012; 53: 313-319.
6. Shirakabe A, Hata N, Kobayashi N, Shinada T, Tomita K, Tsurumi M, et al. Prognostic impact of acute kidney injury in patients with acute decompensated heart failure. Circ J 2013; 77: 687-696.
7. Shrestha K, Shao Z, Singh D, Dupont M, Tang WH. Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failure. Am J Cardiol 2012; 110: 1329-1335.
8. Sato N, Kamiya M, Yoshira A. A novel marker, urinary liver-type fatty acid binding protein for the detection of renal tubular damage in acute decompensated heart failure. J Am Coll Cardiol 2008; 51: A338.
9. Maisel AS, Mueller C, Fitzgerald R, Brikhan R, Hiestand BC, Iqbal N, et al. Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial. Eur J Heart Fail 2011; 13: 846-851.
10. Collins SP, Hart KW, Lindsell CJ, Fermann GJ, Weintraub NL, Miller KF, et al. Elevated urinary neutrophil gelatinase-associated lipocalcin after acute heart failure treatment is associated with worsening renal function and adverse events. Eur J Heart Fail 2012; 14: 1020-1029.
11. Dupont M, Shrestha K, Singh D, Awad A, Kovach C, Scarcipino M, et al. Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure. Eur J Heart Fail 2012; 14: 597-604.
12. Gheorghiade M, Zannad F, Sopko G, Klein L, Pina IL, Konstam MA, et al. Acute heart failure syndromes: Current state and framework for future research. Circulation 2005; 112: 3958-3968.
13. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology: Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787-1847.
14. Mathew TH, Johnson DW, Jones GR. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: Revised recommendations. Med J Aust 2007; 187: 459-463.
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation: Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
16. Iseki K. Chronic kidney disease in Japan. Intern Med 2008; 47: 681-689.
17. Doi K, Negishi K, Ishizu T, Katagiri D, Fujita T, Matsubara T, et al. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit. Crit Care Med 2011; 39: 2464-2469.
18. Matsui K, Kamijo-Ikemori A, Sugaya T, Yasuda T, Kimura K. Usefulness of urinary biomarkers in early detection of acute kidney injury after cardiac surgery in adults. Circ J 2012; 76: 213-220.
19. Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005; 115: 610-621.
20. Endre ZH, Pickering JW, Walker RJ, Devarajan P, Edelstein CL, Bonventre JV, et al. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int 2011; 79: 1119-1130.
21. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiore-nal syndrome. J Am Coll Cardiol 2008; 52: 1527-1539.
22. Ljungman S, Laragh JH, Cody RJ. Role of the kidney in congestive heart failure: Relationship of cardiac index to kidney function. Drugs 1990; 39: 10-24.
23. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009; 53: 589-596.
24. Goto T, Takase H, Toriyama T, Sugiura T, Sato K, Ueda R, et al. Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure. Heart 2003; 89: 1303-1307.
25. Setsuta K, Seino Y, Kitahara Y, Arau M, Ohbayashi T, Takano T, et al. Elevated levels of both cardiomyocyte membrane and myofibril damage markers predict adverse outcomes in patients with chronic heart failure. Circ J 2008; 72: 569-574.